On Tuesday, April 19, 2016, the
President signed into law:
S. 192, the “Older Americans Act
Reauthorization Act of 2016,” which reauthorizes and modifies grant programs
for services to the elderly under the Older Americans Act of 1965;
S. 483, the “Ensuring Patient Access and
Effective Drug Enforcement Act of 2016,” which amends the Controlled Substances
Act to: define "imminent danger to public health or safety" for
the purposes of an immediate suspension or revocation by the Department of
Justice (DOJ) of a registration to manufacture, distribute, or dispense
controlled substances; and provide registrants with the opportunity to submit a
corrective action plan prior to a determination by DOJ to deny or revoke a
registration; and
S. 2512, the “Adding Zika Virus to the
FDA Priority Review Voucher Program Act,” which adds Zika virus to the Food and
Drug Administration priority review voucher program to encourage the
development of treatments for neglected tropical diseases.
Source: The White House, Office of the Press Secretary
No comments:
Post a Comment